Cargando…

Challenges in HIV Vaccine Research for Treatment and Prevention

Many attempts have been made or are ongoing for HIV prevention and HIV cure. Many successes are in the list, particularly for HIV drugs, recently proposed also for prevention. However, no eradication of infection has been achieved so far with any drug. Further, a residual immune dysregulation associ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ensoli, Barbara, Cafaro, Aurelio, Monini, Paolo, Marcotullio, Simone, Ensoli, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157563/ https://www.ncbi.nlm.nih.gov/pubmed/25250026 http://dx.doi.org/10.3389/fimmu.2014.00417

Ejemplares similares

Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study
por: Sgadari, Cecilia, et al.
Publicado: (2019)

Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease
por: Cafaro, Aurelio, et al.
Publicado: (2019)

New insights into pathogenesis point to HIV-1 Tat as a key vaccine target
por: Ensoli, Barbara, et al.
Publicado: (2021)

The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies
por: Barillari, Giovanni, et al.
Publicado: (2018)

The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation
por: Nicoli, Francesco, et al.
Publicado: (2020)

HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology
por: Cafaro, Aurelio, et al.
Publicado: (2016)

Anti-Tat immunity defines CD4(+) T-cell dynamics in people living with HIV on long-term cART.
por: Tripiciano, Antonella, et al.
Publicado: (2021)

HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication
por: Cafaro, Aurelio, et al.
Publicado: (2020)

HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial
por: Ensoli, Barbara, et al.
Publicado: (2016)

The HIV-1 Tat Protein Induces the Activation of CD8(+) T Cells and Affects In Vivo the Magnitude and Kinetics of Antiviral Responses
por: Nicoli, Francesco, et al.
Publicado: (2013)

An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge
por: Sicurella, Mariaconcetta, et al.
Publicado: (2014)

Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort
por: Nicoli, Francesco, et al.
Publicado: (2016)

HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial
por: Ensoli, Fabrizio, et al.
Publicado: (2015)

The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4(+) T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study
por: Bellino, Stefania, et al.
Publicado: (2014)

Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART
por: Ensoli, Barbara, et al.
Publicado: (2010)

Biocompatible Anionic Polymeric Microspheres as Priming Delivery System for Effetive HIV/AIDS Tat-Based Vaccines
por: Titti, Fausto, et al.
Publicado: (2014)

Fibroblast Growth Factor-2 and the HIV-1 Tat Protein Synergize in Promoting Bcl-2 Expression and Preventing Endothelial Cell Apoptosis: Implications for the Pathogenesis of AIDS-Associated Kaposi's Sarcoma
por: Sgadari, Cecilia, et al.
Publicado: (2011)

Non-neutralizing antibodies and vaccine-induced protection
por: Demberg, Thorsten, et al.
Publicado: (2006)

Induction of Antibodies and T Cell Responses by a Recombinant Influenza Virus Carrying an HIV-1 TatΔ(51–59) Protein in Mice
por: Garulli, B., et al.
Publicado: (2014)

Effect of MHC Haplotype on Immune Response upon Experimental SHIV(SF162P4cy) Infection of Mauritian Cynomolgus Macaques
por: Borsetti, Alessandra, et al.
Publicado: (2014)

HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies
por: Monini, Paolo, et al.
Publicado: (2012)

Entrance of the Tat protein of HIV-1 into human uterine cervical carcinoma cells causes upregulation of HPV-E6 expression and a decrease in p53 protein levels
por: Barillari, Giovanni, et al.
Publicado: (2016)

Comment on “Intravitreal Ampicillin Sodium for Antibiotic-Resistant Endophthalmitis: Streptococcus uberis First Human Intraocular Infection Report”
por: Toma, Luigi, et al.
Publicado: (2014)

Molecular Characterization of HIV-1 Subtype C gp-120 Regions Potentially Involved in Virus Adaptive Mechanisms
por: Cenci, Alessandra, et al.
Publicado: (2014)

Hepatitis C Virus Infection Among non-IDU HIV-Infected and Uninfected Men who Have Sex with Men
por: Giuliani, Massimo, et al.
Publicado: (2011)

Design Challenges for HIV-1 Vaccines Based on Humoral Immunity
por: Greenspan, Neil S.
Publicado: (2014)

Kaposi’s Sarcoma Lesion Progression in BKV-Tat Transgenic Mice Is Increased by Inflammatory Cytokines and Blocked by Treatment with Anti-Tat Antibodies
por: Brocca-Cofano, Egidio, et al.
Publicado: (2022)

Editorial: Paradigm Changes are Required in HIV Vaccine Research
por: Van Regenmortel, Marc H. V.
Publicado: (2015)

Biofilm Producing Salmonella Typhi: Chronic Colonization and Development of Gallbladder Cancer
por: Di Domenico, Enea Gino, et al.
Publicado: (2017)

Challenges for Clinical Development of Vaccines for Prevention of Hospital-Acquired Bacterial Infections
por: Bekeredjian-Ding, Isabelle
Publicado: (2020)

Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives
por: Wagner, Angelika, et al.
Publicado: (2020)

Human herpesvirus-8 and other viral infections, Papua New Guinea.
por: Rezza, G, et al.
Publicado: (2001)

How can we design better vaccines to prevent HIV infection in women?
por: Rafferty, Hannah, et al.
Publicado: (2014)

Development of a Preventive HIV Vaccine Requires Solving Inverse Problems Which Is Unattainable by Rational Vaccine Design
por: Van Regenmortel, Marc H. V.
Publicado: (2018)

Developing an Integrated, Brief Biobehavioral HIV Prevention Intervention for High-Risk Drug Users in Treatment: The Process and Outcome of Formative Research
por: Shrestha, Roman, et al.
Publicado: (2017)

Editorial: Why Vaccines to HIV, HCV, and Malaria Have So Far Failed—Challenges to Developing Vaccines Against Immunoregulating Pathogens
por: Li, Shuo, et al.
Publicado: (2015)

Staphylococcus aureus and the Cutaneous Microbiota Biofilms in the Pathogenesis of Atopic Dermatitis
por: Di Domenico, Enea Gino, et al.
Publicado: (2019)

Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells
por: Bacigalupo, Ilaria, et al.
Publicado: (2017)

Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention
por: Corulli, Lauren R., et al.
Publicado: (2021)

Current status of vaccine research, development, and challenges of vaccines for Mycoplasma gallisepticum
por: Ishfaq, Muhammad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mnom92e61mg3fridlkcb8106l2